{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T17:31:28Z","timestamp":1773855088886,"version":"3.50.1"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1097\/md.0000000000000204","type":"journal-article","created":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T14:51:29Z","timestamp":1420728689000},"page":"e204","source":"Crossref","is-referenced-by-count":23,"title":["Prior to the Oral Therapy, What Do We Know About HCV-4 in Egypt"],"prefix":"10.1097","volume":"93","author":[{"given":"Abd Elrazek","family":"Abd Elrazek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shymaa E.","family":"Bilasy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abduh E. M.","family":"Elbanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abd Elhalim A.","family":"Elsherif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210309","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.","volume":"57","author":"Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"key":"R2-8-20210309","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1099\/0022-1317-82-4-693","article-title":"The origin and evolution of hepatitis viruses in humans.","volume":"82","author":"Simmonds","year":"2001","journal-title":"J Gen Virol"},{"key":"R3-8-20210309","doi-asserted-by":"crossref","first-page":"7555","DOI":"10.3748\/wjg.v20.i24.7555","article-title":"Impact of hepatitis C virus heterogeneity on interferon sensitivity: an overview.","volume":"20","author":"El-Shamy","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R4-8-20210309","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4254\/wjh.v5.i7.393","article-title":"Hepatitis C virus genotypes in north eastern Algeria: a retrospective study.","volume":"5","author":"Rouabhia","year":"2013","journal-title":"World J Hepatol"},{"key":"R5-8-20210309","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrgastro.2013.107","article-title":"Epidemiology and natural history of HCV infection.","volume":"10","author":"Hajarizadeh","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R6-8-20210309","first-page":"5193","article-title":"Hepatocellular carcinoma in Egypt: a single center study over a decade.","volume":"11","author":"El-Zayadi","year":"2005","journal-title":"World J Gastroenterol"},{"key":"R7-8-20210309","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1517\/14656566.2014.857656","article-title":"Sofosbuvir for the treatment of hepatitis C virus.","volume":"15","author":"Asselah","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"R8-8-20210309","doi-asserted-by":"crossref","first-page":"e61134","DOI":"10.1371\/journal.pone.0061134","article-title":"From data towards knowledge: revealing the architecture of signaling systems by unifying knowledge mining and data mining of systematic perturbation data.","volume":"8","author":"Lu","year":"2013","journal-title":"PLoS ONE"},{"key":"R9-8-20210309","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/hep.510260338","article-title":"Hepatitis C virus: epidemiology and transmission.","volume":"26","author":"Heintges","year":"1997","journal-title":"Hepatology"},{"key":"R10-8-20210309","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2010.07.009","article-title":"A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin.","volume":"139","author":"Swain","year":"2010","journal-title":"Gastroenterology"},{"key":"R11-8-20210309","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies.","volume":"13","author":"Micallef","year":"2006","journal-title":"J Viral Hepat"},{"key":"R12-8-20210309","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1348-0421.2006.tb03813.x","article-title":"Prevalence of low positive anti-HCV antibodies in blood donors: schistosoma mansoni co-infection and possible role of autoantibodies.","volume":"50","author":"Agha","year":"2006","journal-title":"Microbiol Immunol"},{"key":"R13-8-20210309","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2893.2011.01576.x","article-title":"HCV burden of infection in Egypt: results from a nationwide survey.","volume":"19","author":"Guerra","year":"2012","journal-title":"J Viral Hepat"},{"key":"R14-8-20210309","first-page":"41","article-title":"Epidemiology of HCV in Egypt 2004.","volume":"13","author":"Mohamed","year":"2004","journal-title":"Afro-Arab Liver J"},{"key":"R15-8-20210309","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/1471-2334-13-288","article-title":"The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis.","volume":"13","author":"Mohamoud","year":"2013","journal-title":"BMC Infect Dis"},{"key":"R16-8-20210309","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/jhep.2001.20797","article-title":"Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity.","volume":"13","author":"Habib","year":"2001","journal-title":"Hepatology"},{"key":"R17-8-20210309","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1348-0421.2010.00268.x","article-title":"17-Estradiol inhibits the production of infectious particles of hepatitis C virus.","volume":"54","author":"Hayashida","year":"2010","journal-title":"Microbiol Immunol"},{"key":"R18-8-20210309","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s10096-013-2038-y","article-title":"Association of genetic variants in estrogen receptor with HCV infection susceptibility and viral clearance in a high-risk Chinese population.","volume":"33","author":"Tang","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R19-8-20210309","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1034\/j.1600-0676.2003.00811.x","article-title":"Impact of oestrogens on the progression of liver disease.","volume":"23","author":"Shimizu","year":"2003","journal-title":"Liver Int"},{"key":"R20-8-20210309","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0168-8278(00)00097-0","article-title":"Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.","volume":"34","author":"Poynard","year":"2001","journal-title":"J Hepatol"},{"key":"R21-8-20210309","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1872-034X.2007.00032.x","article-title":"Protection of estrogens against the progression of chronic liver disease.","volume":"37","author":"Shimizu","year":"2007","journal-title":"Hepatol Res"},{"key":"R22-8-20210309","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1365-2036.2012.04992.x","article-title":"UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients.","volume":"35","author":"Ramachandran","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"R23-8-20210309","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/hep.24641","article-title":"An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases.","volume":"54","author":"Ghany","year":"2011","journal-title":"Hepatology"},{"key":"R24-8-20210309","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1128\/JCM.02109-12","article-title":"NS5A sequence heterogeneity of hepatitis C virus genotype 4a predicts clinical outcome of pegylated-interferon-ribavirin therapy in Egyptian patients.","volume":"50","author":"El-Shamy","year":"2012","journal-title":"J Clin Microbiol"},{"key":"R25-8-20210309","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jhep.2011.09.008","article-title":"IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C.","volume":"56","author":"Asselah","year":"2012","journal-title":"J Hepatol"},{"key":"R26-8-20210309","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/hep.24683","article-title":"Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4.","volume":"55","author":"De Nicola","year":"2012","journal-title":"Hepatology"},{"key":"R27-8-20210309","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.3748\/wjg.v19.i17.2691","article-title":"Coinfection with hepatitis C virus and schistosomiasis: fibrosis and treatment response.","volume":"19","author":"Abdel-Rahman","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R28-8-20210309","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/MAJ.0b013e3182750ce8","article-title":"Detection of risky esophageal varices by two-dimensional ultrasound: when to perform endoscopy.","volume":"347","author":"Razek Abd El, Mahfouz Hamdy","year":"2014","journal-title":"Am J Med Sci"},{"key":"R30-8-20210309","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1034\/j.1600-0676.2000.020004281.x","article-title":"Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni.","volume":"20","author":"Kamal","year":"2000","journal-title":"Liver"},{"key":"R31-8-20210309","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10029-005-0022-x","article-title":"Poor outcomes in cirrhosis-associated hernia repair: a nationwide cohort study of 32,033 patients.","volume":"9","author":"Carbonell","year":"2005","journal-title":"Hernia"},{"key":"R32-8-20210309","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.surg.2007.05.006","article-title":"Management in patients with liver cirrhosis and an umbilical hernia.","volume":"142","author":"Marsman","year":"2007","journal-title":"Surgery"},{"key":"R33-8-20210309","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/MAJ.0b013e3181f31932","article-title":"Surgical repair of umbilical hernias in cirrhosis with ascites.","volume":"341","author":"Triantos","year":"2011","journal-title":"Am J Med Sci"},{"key":"R34-8-20210309","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1053\/jlts.2003.50078","article-title":"Minimally invasive repair of recurrent strangulated umbilical hernia in cirrhotic patient with refractory ascites.","volume":"9","author":"Sarit","year":"2003","journal-title":"Liver Transplant"},{"key":"R35-8-20210309","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/109264203769681745","article-title":"A novel technique to treat ruptured umbilical hernias in patients with liver cirrhosis and severe ascites.","volume":"13","author":"Melcher","year":"2003","journal-title":"J Laparoendosc Adv Surg Tech A"},{"key":"R36-8-20210309","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/01.meg.0000236872.85903.3f","article-title":"Transjugular intrahepatic portosystemic shunt in the management of ascites and hepatorenal syndrome.","volume":"18","author":"Senzolo","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R37-8-20210309","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/01.sle.0000213745.15773.c1","article-title":"Laparoscopic incisional and umbilical hernia repair in cirrhotic patients.","volume":"16","author":"Belli","year":"2006","journal-title":"Surg Laparosc Endosc Percutan Tech"},{"key":"R39-8-20210309","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MEG.0b013e328365c3b0","article-title":"Mortality prediction of non-alcoholic patients presenting with upper gastrointestinal bleeding using data mining.","volume":"26","author":"Abd Elrazek","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R40-8-20210309","first-page":"1","article-title":"Prediction analysis of esophageal variceal degrees using data mining: is validated in clinical medicine Global J Comput Sci T","volume":"13","author":"Aly abd Elrazek Abd Elrazek","year":"2013","journal-title":"echnol"},{"key":"R41-8-20210309","first-page":"31","article-title":"Is advanced statistical computing technology a clue in applied medicine A study using data mining as a predictor technology in gastroenterology bariatric surgery; novel elbanna operations.","volume":"13","author":"Elbanna","year":"2013","journal-title":"Global J Comput Sci Technol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000000204","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:38:22Z","timestamp":1620959902000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201412030-00008"}},"subtitle":["A Randomized Survey of Prevalence and Risks Using Data Mining Computed Analysis"],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":39,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000000204","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}